Valuation: IRADIMED CORPORATION

Market Cap 1.16B 1.01B 940M 863M 1.63B 111B 1.66B 11.08B 4.35B 55.22B 4.36B 4.27B 185B P/E 2026 *
47.6x
P/E 2027 * 41x
Enterprise Value 1.16B 1.01B 940M 863M 1.63B 111B 1.66B 11.08B 4.35B 55.22B 4.36B 4.27B 185B EV / Sales 2026 *
12.7x
EV / Sales 2027 * 11.5x
Free-Float
64.8%
Yield 2026 *
-
Yield 2027 * -
1 day-4.57%
1 week-3.84%
1 month-10.01%
3 months+4.26%
6 months-8.22%
Current year-6.60%
1 week 89.51
Extreme 89.51
97.74
1 month 89.51
Extreme 89.51
102.99
Current year 76.95
Extreme 76.95
107.9
1 year 66.78
Extreme 66.78
107.9
3 years 36.12
Extreme 36.12
107.9
5 years 26
Extreme 26
107.9
10 years 7.85
Extreme 7.85
107.9
Manager TitleAgeSince
Chief Executive Officer 72 28/05/2020
Director of Finance/CFO 64 20/06/2022
Chief Tech/Sci/R&D Officer - 01/01/2020
Director TitleAgeSince
Chairman 72 16/06/2020
Director/Board Member 70 01/01/2019
Director/Board Member 73 01/01/2014
Date Insider Type Main position Quantity % Market Cap.
30/3/26 Sell

Chief Executive Officer

7,500 0.0590%
13/2/26 Sell

Director

1,000 0.0079%
26/1/26 Sell

Chief Executive Officer

5,000 0.0393%
Change 5-day change 1-year change 3-year change Capi.($)
-4.57%-3.84%+37.31%+107.77% 1.16B
-0.84%+5.24%-13.34%-15.70% 14.02B
+4.81%-6.82%+38.55%-8.85% 3.9B
+1.81%+11.70%-36.35%-53.93% 1.27B
+1.98%+9.99%-35.86%-42.87% 1.18B
+1.35%+5.63%-45.42% - 952M
+17.03%+10.93%+29.15%+103.79% 500M
-1.79%+1.39%+68.29% - 329M
+0.36%+2.02%-59.27%+221.90% 265M
+4.47%-4.22%+8.46%+37.31% 135M
Average +2.46%+0.83%-0.85%+43.68% 2.37B
Weighted average by Cap. +0.68%+2.12%-4.34%-5.93%

Financials

2026 *2027 *
Net sales 91.2M 79.28M 73.79M 67.75M 128M 8.71B 130M 870M 341M 4.33B 343M 335M 14.53B 101M 87.71M 81.64M 74.96M 142M 9.63B 144M 962M 378M 4.8B 379M 371M 16.08B
Net income 24.55M 21.34M 19.86M 18.24M 34.44M 2.34B 34.97M 234M 91.9M 1.17B 92.2M 90.17M 3.91B 28.4M 24.69M 22.98M 21.1M 39.84M 2.71B 40.46M 271M 106M 1.35B 107M 104M 4.53B
Net Debt - -
Logo IRADIMED CORPORATION
IRadimed Corporation develops, manufactures, markets and distributes magnetic resonance imaging (MRI) compatible medical devices and accessories, disposables and services. Its MRidium 3870 MRI Compatible IV infusion pump system provides a non-magnetic Intravenous (IV) infusion pump system that is specifically designed for safe use during MRI procedures. Its MRidium 3860+ MRI Compatible IV infusion pump system has been designed with a non-magnetic ultrasonic motor with non-ferrous parts and other special features to safely and predictably and other IV fluids during various MRI procedures. Its IRadimed 3880 MRI Compatible patient vital signs monitoring system has been designed with non-magnetic components and other features to safely and accurately during various MRI procedures. The Company sells its products primarily to hospitals and acute care facilities. The IRADIMED 3880 system operates dependably on magnetic fields of over 30,000 gauss.
Employees
166
Date Price Change Volume
31/07/26 USD 90.86 -4.57% 308,081
30/07/26 USD 95.21 +1.01% 122,193
29/07/26 USD 94.26 -0.60% 111,507
28/07/26 USD 94.83 -0.26% 113,775
27/07/26 USD 95.08 +0.62% 67,185
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
B
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
90.86USD
Average target price
118.00USD
Spread / Average Target
+29.87%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. IRMD Stock